CytRx Announces Significant Efficacy Results In A Pre-Clinical Trial With Iroxanadine For Diabetic Peripheral Neuropathy

Podiatry Arena CytRx Announces Significant Efficacy Results In A Pre-Clinical Trial With Iroxanadine For Diabetic Peripheral Neuropathy

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

CytRx Announces Significant Efficacy Results In A Pre-Clinical Trial With Iroxanadine For Diabetic Peripheral Neuropathy

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

20th March 2009, 05:10 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 3,061

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 5 Times in 5 Posts

CytRx Announces Significant Efficacy Results In A Pre-Clinical Trial With Iroxanadine For Diabetic Peripheral Neuropathy

Podiatry Arena members do not see these ads

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, announced that its molecular chaperone amplifying drug candidate iroxanadine has been shown to be effective in protecting against diabetic peripheral neuropathy (DPN) in animals.

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Clinical Trial of Excellarate(TM) for Diabetic Ulcers	NewsBot	Diabetic Foot & Wound Management	5	7th May 2009 03:27 AM
Synvista Therapeutics Announces First Dosing Of SYI-2074 In Clinical Trial For Psoriasis	RSSFeedBot	Latest Dermatology News	0	16th December 2008 07:30 AM
Ethnic differences in plantar pressures in diabetic patients with peripheral neuropathy	NewsBot	Diabetic Foot & Wound Management	2	28th November 2008 06:32 AM
Teaching the assessment of diabetic patients for peripheral neuropathy	rrama	Teaching and Learning	6	8th July 2008 05:48 PM
Exercise improves diabetic peripheral neuropathy	NewsBot	Diabetic Foot & Wound Management	1	24th June 2006 01:26 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 03:54 PM.

User Name		Remember Me?
Password